Literature DB >> 30638710

A systemic workflow for profiling metabolome and lipidome in tissue.

Dasheng Lu1, Liming Xue2, Chao Feng2, Yu'e Jin2, Chunhua Wu3, Cen Xie4, Frank J Gonzalez4, Guoquan Wang5, Zhijun Zhou6.   

Abstract

Simple metabolome and lipidome sample preparation procedures involving two successive extractions using small pieces of tissue, and a subsequent metabolite identification (MetID) strategy were developed. The sample preparation can significantly circumvent incomplete analysis due to insufficient amounts of tissue as a result of splitting into several aliquots for multiple measurements, with advantages over the similar previously reported methods in metabolite coverage, extraction efficiency, method robustness and friendly experimental operation. A MetID strategy, based on the integration of MS information mining (including adduct ions, in-source CID, MS information from both ESI (+) and ESI (-), characteristic fragmentation ions (CFIs), constant neutral losses (CNLs) and multimers) and in silico MS simulation, was demonstrated. A large number of adduct ions (83 features), in-source CID (123 features), ESI (+/-) ionization (20 features), CFIs& CNLs (more than 120 features) and multimers (17 features) were mined by manually or in silico recognition/filtering, which provide the most suspicious structures for subsequent in silico MS simulation. The unknown features presented the same score distribution as the known (83 features) features with scores ≥25% (geomean score: 52%) and with satisfactory match for the main ions of interest. The MS/MS noise and fragment ions of coeluted quasi-molecular ions of interest are the main reason for the low score in the simulation. Manual check/evaluation is always suggested for the simulation with a score less than 50%. This strategy presents satisfactory performance with 2.5 times more metabolites structurally characterized compared with that of the traditional method based on accurate-mass-based MS and MS/MS library matching. This strategy would be useful for potentially identifying metabolites without available MS/MS information in the library.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  In silico MS simulation; Lipidome; MS information mining; Metabolome

Mesh:

Year:  2018        PMID: 30638710      PMCID: PMC6628932          DOI: 10.1016/j.chroma.2018.12.061

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  5 in total

1.  Helicobacter pylori infection worsens impaired glucose regulation in high-fat diet mice in association with an altered gut microbiome and metabolome.

Authors:  Chao Peng; Xinbo Xu; Zichuan He; Nianshuang Li; Yaobin Ouyang; Yin Zhu; Nonghua Lu; Cong He
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-12       Impact factor: 4.813

2.  Characterization of metabolites and biomarkers for the probiotic effects of Clostridium cochlearium on high-fat diet-induced obese C57BL/6 mice.

Authors:  Fei Yang; Wenjun Zhu; Paba Edirisuriya; Qing Ai; Kai Nie; Xiangming Ji; Kequan Zhou
Journal:  Eur J Nutr       Date:  2022-03-20       Impact factor: 5.614

3.  Sarcopenic metabolomic profile reflected a sarcopenic phenotype associated with amino acid and essential fatty acid changes.

Authors:  Rafael Opazo; Bárbara Angel; Carlos Márquez; Lydia Lera; Gustavo R Cardoso Dos Santos; Gustavo Monnerat; Cecilia Albala
Journal:  Metabolomics       Date:  2021-09-08       Impact factor: 4.290

4.  Characterization and identification of charcoal of inedible Kerandang fish (Channa pleurophthalmus Blkr) body parts and potential antiallergenic properties.

Authors:  Aryani Aryani; Eddy Suprayitno; Bambang Budi Sasmito; Hardoko Hardoko
Journal:  Vet World       Date:  2020-07-30

5.  Recurrent Topics in Mass Spectrometry-Based Metabolomics and Lipidomics-Standardization, Coverage, and Throughput.

Authors:  Evelyn Rampler; Yasin El Abiead; Harald Schoeny; Mate Rusz; Felina Hildebrand; Veronika Fitz; Gunda Koellensperger
Journal:  Anal Chem       Date:  2020-11-28       Impact factor: 6.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.